Megan E. Meuser

511 total citations
17 papers, 424 citations indexed

About

Megan E. Meuser is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Megan E. Meuser has authored 17 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Virology, 14 papers in Infectious Diseases and 5 papers in Molecular Biology. Recurrent topics in Megan E. Meuser's work include HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Click Chemistry and Applications (4 papers). Megan E. Meuser is often cited by papers focused on HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers) and Click Chemistry and Applications (4 papers). Megan E. Meuser collaborates with scholars based in United States, Jordan and China. Megan E. Meuser's co-authors include Simon Cocklin, Alexej Dick, Xinyong Liu, Waleed A. Zalloum, Chin‐Ho Chen, Kuo‐Hsiung Lee, Lin Sun, Dongwei Kang, Xiao Ding and Ping Gao and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Journal of Medicinal Chemistry.

In The Last Decade

Megan E. Meuser

17 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan E. Meuser United States 11 241 223 169 149 58 17 424
Joan Zugay-Murphy United States 8 130 0.5× 103 0.5× 68 0.4× 202 1.4× 55 0.9× 9 363
Charles E. Nichols United Kingdom 10 173 0.7× 121 0.5× 79 0.5× 189 1.3× 14 0.2× 11 373
Mary C. Casey United States 13 242 1.0× 204 0.9× 55 0.3× 144 1.0× 29 0.5× 20 337
S.L. Irving United Kingdom 7 186 0.8× 218 1.0× 152 0.9× 326 2.2× 22 0.4× 8 547
Takuya Kobayakawa Japan 11 180 0.7× 165 0.7× 103 0.6× 191 1.3× 8 0.1× 44 378
Jared Lindenberger United States 11 164 0.7× 98 0.4× 80 0.5× 169 1.1× 10 0.2× 20 339
Dawn D. Parker United States 13 203 0.8× 168 0.8× 137 0.8× 154 1.0× 145 2.5× 22 498
Dorothée Bardiot Belgium 6 310 1.3× 256 1.1× 103 0.6× 247 1.7× 11 0.2× 9 505
T. J. MCQUADE United States 5 388 1.6× 360 1.6× 78 0.5× 184 1.2× 33 0.6× 5 539
Pratiq A. Patel United States 7 295 1.2× 301 1.3× 54 0.3× 268 1.8× 8 0.1× 7 412

Countries citing papers authored by Megan E. Meuser

Since Specialization
Citations

This map shows the geographic impact of Megan E. Meuser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan E. Meuser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan E. Meuser more than expected).

Fields of papers citing papers by Megan E. Meuser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan E. Meuser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan E. Meuser. The network helps show where Megan E. Meuser may publish in the future.

Co-authorship network of co-authors of Megan E. Meuser

This figure shows the co-authorship network connecting the top 25 collaborators of Megan E. Meuser. A scholar is included among the top collaborators of Megan E. Meuser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan E. Meuser. Megan E. Meuser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Wu, Chunxiang, Megan E. Meuser, Swapnil C. Devarkar, et al.. (2025). Distinct Target Site of Lenacapavir in Immature HIV-1 and Concurrent Binding with the Maturation Inhibitor Bevirimat. Journal of the American Chemical Society. 147(46). 42685–42700. 1 indexed citations
2.
Dick, Alexej, Megan E. Meuser, & Simon Cocklin. (2022). Clade-Specific Alterations within the HIV-1 Capsid Protein with Implications for Nuclear Translocation. Biomolecules. 12(5). 695–695. 2 indexed citations
3.
Meuser, Megan E., et al.. (2021). Rapid Optimization of the Metabolic Stability of a Human Immunodeficiency Virus Type-1 Capsid Inhibitor Using a Multistep Computational Workflow. Journal of Medicinal Chemistry. 64(7). 3747–3766. 17 indexed citations
4.
Zhang, Xujie, Lin Sun, Megan E. Meuser, et al.. (2021). Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors. European Journal of Medicinal Chemistry. 226. 113848–113848. 15 indexed citations
5.
Meuser, Megan E., et al.. (2021). Structure, Function, and Interactions of the HIV-1 Capsid Protein. Life. 11(2). 100–100. 46 indexed citations
6.
Xu, Shujing, Lin Sun, Alexej Dick, et al.. (2021). Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability. European Journal of Medicinal Chemistry. 227. 113903–113903. 22 indexed citations
7.
Ke, Na, Guoping Ren, Megan E. Meuser, et al.. (2021). A useful epitope tag derived from maltose binding protein. Protein Science. 30(6). 1235–1246. 9 indexed citations
8.
Sun, Lin, Alexej Dick, Megan E. Meuser, et al.. (2020). Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities. European Journal of Medicinal Chemistry. 190. 112085–112085. 92 indexed citations
9.
Sun, Lin, Alexej Dick, Megan E. Meuser, et al.. (2020). Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities. Journal of Medicinal Chemistry. 63(9). 4790–4810. 46 indexed citations
10.
Meuser, Megan E., et al.. (2020). Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic Stability. Molecules. 25(6). 1430–1430. 12 indexed citations
11.
Jiang, Xiangyi, Gaochan Wu, Waleed A. Zalloum, et al.. (2019). Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors. RSC Advances. 9(50). 28961–28986. 53 indexed citations
12.
Meuser, Megan E., Michael Murphy, Adel A. Rashad, & Simon Cocklin. (2019). Kinetic Characterization of Novel HIV-1 Entry Inhibitors: Discovery of a Relationship between Off-Rate and Potency. SHILAP Revista de lepidopterología. 77–77. 1 indexed citations
13.
Meuser, Megan E., Adel A. Rashad, Gabriel Ozorowski, et al.. (2019). Field-Based Affinity Optimization of a Novel Azabicyclohexane Scaffold HIV-1 Entry Inhibitor. Molecules. 24(8). 1581–1581. 8 indexed citations
14.
Meuser, Megan E., Michael Murphy, Adel A. Rashad, & Simon Cocklin. (2018). Kinetic Characterization of Novel HIV-1 Entry Inhibitors: Discovery of a Relationship between Off-Rate and Potency. Molecules. 23(8). 1940–1940. 10 indexed citations
15.
Wu, Gaochan, Waleed A. Zalloum, Megan E. Meuser, et al.. (2018). Discovery of phenylalanine derivatives as potent HIV-1 capsid inhibitors from click chemistry-based compound library. European Journal of Medicinal Chemistry. 158. 478–492. 55 indexed citations
16.
Xu, Jimmy P., Ashwanth C. Francis, Megan E. Meuser, et al.. (2018). Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.. PubMed. 5(2). 33 indexed citations
17.
Gertz, Jacqueline M., Megan E. Meuser, & Beth A. Bouchard. (2017). Simultaneous flow cytometric analysis of megakaryocyte polyploidy and a labile intracellular protein using zinc‐based fixation. Cytometry Part A. 91(7). 713–720. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026